Antibacterial micro/nanomotors: current research progress, challenges, and opportunities.

Authors:
Liu XY; Li RF; Jia J; Yu ZL.

Journal:
Theranostics

Publication Year: 2024

DOI:
10.7150/thno.92449

PMCID:
PMC10797294

PMID:
38250044

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Theranostics

Abbreviation: Theranostics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
20-HETE mediated TRPV1 activation drives allokinesis via MrgprA3<sup>+</sup> neurons in chronic der…
Yu G; Liu P; Huang X and 11 more (2024) - Transparency Score: 3/6
Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpres…
Amer L; Retout M; Jokerst JV. (2024) - Transparency Score: 3/6
Annotation of CD8<sup>+</sup> T-cell function via ICAM-1 imaging identifies FAK inhibition as an ad…
Zhang T; Zhang Y; Zhao Y and 11 more (2024) - Transparency Score: 3/6
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-N…
Trautwein NF; Schwenck J; Seitz C and 12 more (2024) - Transparency Score: 3/6
Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
Patel SK; Billingsley MM; Mukalel AJ and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing Interests: The authors have declared that no competing interest exists."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (82372102)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025